ARCHIVES

Cyclamate Review Committee Starts Survey; Inventor Castigates NCI

This article is from The Cancer Letter archive.

Vol. 01 No. 37 | September 12, 1975

Download PDF Visit The Full Archive

Related Articles

Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival

August 31, 2012

Guest Editorial by Robert Cook-Deegan: Myriad Case Ruling Likely to Concur With DOJ Arguments

April 19, 2013

FASEB urges 10 percent increase for NIH in FY 2005.

January 23, 2004

Genomic Tests Not Shown To Decrease Deaths, Improve Quality Of Life

October 27, 2006

June Panel Meeting Dropped

June 3, 1977

Sorafenib Targets AML Driven By Mutant FLT3 Gene

February 29, 2008